Steroid versus platelet-rich plasma (PRP) injection for frozen shoulder (STIFF) Trial

Not Applicable

• Conditions: Adhesive capsulitis shoulder (frozen shoulder); Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12622000618752
• Lead Sponsor: Dr Matthew Brick

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-26
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

•Patients aged 18 years or over living in Auckland region
•Specialist-confirmed diagnosis of adhesive capsulitis
•Shoulder pain and restricted range of motion in shoulder
•Symptoms between 1-12 months
•Shoulder radiograph and ultrasound scan. Radiology will document capsular thickness, bursal thickness, prevalence of co-existing calcific tendonitis, rotator cuff tendinopathy/minor tear or joint effusion. These findings are not exclusion criteria.

Exclusion Criteria

•Serious orthopaedic or medical co-morbidity including osteoarthritis, fracture, dislocation, massive rotator cuff tear, infection, malignancy, haematological disorder, chronic regional pain syndrome of the shoulder, crystal arthropathy of shoulder confirmed on previous aspirate, previous shoulder injection within 3 months
•Participants need to avoid steroids and non-steroidal anti-inflammatories (NSAID) in the week prior and week after their injection. This will be screened for during the consent process and immediately before the procedure. Patients using these medications will be deferred to a later procedure day when they haven’t used them for over one week prior.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disabilities of the Arm, Shoulder and Hand shortened version (QuickDASH) Score[2 weeks, 12 weeks, 6 months and 1 year (primary timepoint) post-injection.];Visual Analogue Score (VAS) for Pain[2 weeks, 12 weeks, 6 months and 1 year (primary timepoint) post-injection.];Shoulder Pain and Disability Index (SPADI) Total Score. [2 weeks, 12 weeks, 6 months and 1 year (primary timepoint) post-injection.]